- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
GMAB
CPH
Week ended 07 Aug 2026
Weekly Investor Report
Genmab A/S · Healthcare · Biotechnology
Latest close
1,999 DKK
7.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 11.0% above the Trend Line and sits at 72.0% of its 52-week range. The latest completed week returned 7.6%, after a 7.0% four-week move. The latest news-sentiment score is 57/100.
Setup score
57
out of 100
Latest Close
1,999 DKK
7 Aug 2026
1W Return
7.6%
latest completed week
4W Return
7.0%
short-term follow-through
12W Return
18.7%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.6%
Latest completed week; four-week move 7.0%.
Indicator stack
28/83
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
57/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 11.0% above the Trend Line and sits at 72.0% of its 52-week range. The latest completed week returned 7.6%, after a 7.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3512-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.35Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.0% over four weeks, 18.7% over 12 weeks, and 44.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.99Latest activity-pressure read.
Pressure change194.5%Four-week change in activity pressure.
Leadership3.18Latest relative-leadership reading.
RS change191.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 12 relevant articles.
4 positive · 6 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.4%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2612 weeks finished lower.
Best week+9.8%Week of 3 Jul.
Worst week-7.1%Week of 5 Jun.
Latest week+7.6%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains9
Flat weeks1
Modest losses9
Sharp losses3
Recent vol4.0%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split30/21Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank9 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Biotechnology
4-week rank4 / 7
Group average9.6%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD71.4%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 1/12.
Activity pressure 0.35; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 12 relevant articles.
Legacy Wealth Asset Management LLC Grows Stake in Genmab A/S Sponsored ADR $GMAB Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,999 DKK | 7.6% | 1,802 DKK | 1,813 DKK | 0.99 | 3.18 | 667.3K | Off |
| 31 Jul 2026 | 1,858 DKK | -1.1% | 1,808 DKK | 1,817 DKK | 0.93 | -3.36 | 489.9K | Off |
| 24 Jul 2026 | 1,878 DKK | 0.5% | 1,813 DKK | 1,821 DKK | 0.86 | -1.48 | 474.3K | Off |
| 17 Jul 2026 | 1,869 DKK | 0.0% | 1,821 DKK | 1,827 DKK | 0.66 | -5.30 | 648.8K | Off |
| 10 Jul 2026 | 1,868 DKK | 0.0% | 1,827 DKK | 1,832 DKK | 0.34 | -3.49 | 683.3K | Off |
| 3 Jul 2026 | 1,868 DKK | 9.8% | 1,832 DKK | 1,837 DKK | -0.05 | -4.37 | 98.2K | Off |
| 26 Jun 2026 | 1,702 DKK | 4.0% | 1,837 DKK | 1,842 DKK | -0.29 | -7.90 | 118.6K | Off |
| 19 Jun 2026 | 1,636 DKK | 1.1% | 1,849 DKK | 1,847 DKK | -0.23 | -8.24 | 228.6K | Off |
| 12 Jun 2026 | 1,619 DKK | 2.2% | 1,860 DKK | 1,854 DKK | -0.16 | -10.37 | 88.4K | Off |
| 5 Jun 2026 | 1,584 DKK | -7.1% | 1,871 DKK | 1,861 DKK | -0.28 | -11.44 | 827.2K | Off |
| 29 May 2026 | 1,704 DKK | -1.1% | 1,880 DKK | 1,868 DKK | -0.46 | -6.04 | 1.1M | Off |
| 22 May 2026 | 1,724 DKK | 2.3% | 1,884 DKK | 1,874 DKK | -0.88 | -4.71 | 846.3K | Off |
| 15 May 2026 | 1,684 DKK | 2.6% | 1,890 DKK | 1,881 DKK | -1.19 | -5.59 | 532.9K | Off |
| 8 May 2026 | 1,642 DKK | -3.1% | 1,904 DKK | 1,888 DKK | -1.23 | -6.41 | 1.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.